1-5 of 5
Robert S. Svatek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials

Max Kates, Andres Matoso, Woonyoung Choi, Alexander S. Baras, Marcus J. Daniels, Kara Lombardo, Aaron Brant, Nina Mikkilineni, David J. McConkey, Ashish M. Kamat, Robert S. Svatek, Sima P. Porten, Joshua J. Meeks, Seth P. Lerner, Colin P. Dinney, Peter C. Black, James M. McKiernan, Chris Anderson, Charles G. Drake, Trinity J. Bivalacqua
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (4): 882–891.
https://doi.org/10.1158/1078-0432.CCR-19-1920
Published: 14 February 2020
View article titled, Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Open the PDF for Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials in another window
Includes: Supplementary data
Journal Articles

Sequential Intravesical Mitomycin plus Bacillus Calmette–Guérin for Non–Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial

Robert S. Svatek, Xiang Ru. Zhao, Edwin E. Morales, Mithilesh K. Jha, Timothy Y. Tseng, Cory M. Hugen, Vincent Hurez, Javier Hernandez, Tyler J. Curiel
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (2): 303–311.
https://doi.org/10.1158/1078-0432.CCR-14-1781
Published: 14 January 2015
View article titled, Sequential Intravesical Mitomycin plus Bacillus Calmette–Guérin for Non–Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial
Open the PDF for Sequential Intravesical Mitomycin plus Bacillus Calmette–Guérin for Non–Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial in another window
Includes: Supplementary data
Journal Articles

The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder

Robert S. Svatek, Shahrokh F. Shariat, Robert E. Lasky, Eila C. Skinner, Giacomo Novara, Seth P. Lerner, Yves Fradet, Patrick J. Bastian, Wassim Kassouf, Pierre I. Karakiewicz, Hans-Martin Fritsche, Stefan C. Müller, Jonathan I. Izawa, Vincenzo Ficarra, Arthur I. Sagalowsky, Mark P. Schoenberg, Arlene O. Siefker-Radtke, Randall E. Millikan, Colin P.N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (17): 4461–4467.
https://doi.org/10.1158/1078-0432.CCR-10-0457
Published: 31 August 2010
View article titled, The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder
Open the PDF for The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder in another window
Journal Articles

Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy

Robert S. Svatek, Jose A. Karam, Claus G. Roehrborn, Pierre I. Karakiewicz, Kevin M. Slawin, Shahrokh F. Shariat
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3362–3366.
https://doi.org/10.1158/1078-0432.CCR-07-4707
Published: 02 June 2008
View article titled, Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy
Open the PDF for Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy in another window
Journal Articles

Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer

Jose A. Karam, Robert S. Svatek, Pierre I. Karakiewicz, Andrea Gallina, Claus G. Roehrborn, Kevin M. Slawin, Shahrokh F. Shariat
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1418–1422.
https://doi.org/10.1158/1078-0432.CCR-07-0901
Published: 03 March 2008
View article titled, Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer
Open the PDF for Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer in another window